184 related articles for article (PubMed ID: 21722288)
1. Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry.
Dhar N; Ward JF; Cher ML; Jones JS
BJU Int; 2011 Aug; 108(4):508-12. PubMed ID: 21722288
[TBL] [Abstract][Full Text] [Related]
2. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
[TBL] [Abstract][Full Text] [Related]
3. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
4. Salvage prostate cryoablation: initial results from the cryo on-line data registry.
Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS
J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664
[TBL] [Abstract][Full Text] [Related]
5. Definition of biochemical success following primary whole gland prostate cryoablation.
Levy DA; Ross AE; ElShafei A; Krishnan N; Hatem A; Jones JS
J Urol; 2014 Nov; 192(5):1380-4. PubMed ID: 24813344
[TBL] [Abstract][Full Text] [Related]
6. Does neoadjuvant androgen deprivation therapy before primary whole gland cryoablation of the prostate affect the outcome?
Grossgold E; Given R; Ruckle H; Jones JS
Urology; 2014 Feb; 83(2):379-83. PubMed ID: 24315304
[TBL] [Abstract][Full Text] [Related]
7. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry.
Ward JF; Jones JS
BJU Int; 2012 Jun; 109(11):1648-54. PubMed ID: 22035200
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.
Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ
J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496
[TBL] [Abstract][Full Text] [Related]
9. Cryosurgical ablation of the prostate: high risk patient outcomes.
Prepelica KL; Okeke Z; Murphy A; Katz AE
Cancer; 2005 Apr; 103(8):1625-30. PubMed ID: 15747374
[TBL] [Abstract][Full Text] [Related]
10. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation.
Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ
Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436
[TBL] [Abstract][Full Text] [Related]
11. Cryoablation for locally advanced clinical stage T3 prostate cancer: a report from the Cryo-On-Line Database (COLD) Registry.
Ward JF; DiBlasio CJ; Williams C; Given R; Jones JS
BJU Int; 2014 May; 113(5):714-8. PubMed ID: 24112776
[TBL] [Abstract][Full Text] [Related]
12. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry.
Li YH; Elshafei A; Agarwal G; Ruckle H; Powsang J; Jones JS
Prostate; 2015 Jan; 75(1):1-7. PubMed ID: 25283814
[TBL] [Abstract][Full Text] [Related]
13. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
Pfeiffer D; Berger J; Gross AJ
BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
[TBL] [Abstract][Full Text] [Related]
14. Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.
Gondi V; Deutsch I; Mansukhani M; O'Toole KM; Shah JN; Schiff PB; Katz AE; Benson MC; Goluboff ET; Ennis RD
Urology; 2007 Mar; 69(3):541-6. PubMed ID: 17382161
[TBL] [Abstract][Full Text] [Related]
15. Only carefully selected patients may have a beneficial effect of salvage cryoablation in recurrent prostate cancer after radiotherapy.
Elkjær MC; Borre M
Dan Med J; 2013 Dec; 60(12):A4756. PubMed ID: 24355453
[TBL] [Abstract][Full Text] [Related]
16. Primary cryoablation nadir prostate specific antigen and biochemical failure.
Levy DA; Pisters LL; Jones JS
J Urol; 2009 Sep; 182(3):931-7. PubMed ID: 19616226
[TBL] [Abstract][Full Text] [Related]
17. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer.
Bahn DK; Lee F; Badalament R; Kumar A; Greski J; Chernick M
Urology; 2002 Aug; 60(2 Suppl 1):3-11. PubMed ID: 12206842
[TBL] [Abstract][Full Text] [Related]
18. "Male lumpectomy": focal therapy for prostate cancer using cryoablation.
Onik G; Vaughan D; Lotenfoe R; Dineen M; Brady J
Urology; 2007 Dec; 70(6 Suppl):16-21. PubMed ID: 18194706
[TBL] [Abstract][Full Text] [Related]
19. Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data.
Tay KJ; Polascik TJ; Elshafei A; Tsivian E; Jones JS
J Endourol; 2017 Jun; 31(6):564-571. PubMed ID: 28385075
[TBL] [Abstract][Full Text] [Related]
20. Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience.
Busch J; Stephan C; Herold A; Erber B; Kempkensteffen C; Hinz S; Lein M; Weikert S; Miller K; Magheli A
BJU Int; 2012 Dec; 110(11 Pt C):E985-90. PubMed ID: 22672442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
